We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Brookfield Renewable
BEPC
$6.15B
| $4.35M | 0.02% |
137,875
-176
| -0.1% | -$5.94K |
|
227
Constellation Brands
STZ
$22.3B
| $4.25M | 0.02% |
17,268
-75
| -0.4% | -$17.5K |
|
228
Esquire Financial Holdings
ESQ
$1.03B
| $4.23M | 0.02% |
92,500
| – | – |
|
229
Eaton
ETN
$159B
| $4.23M | 0.02% |
21,027
-55
| -0.3% | -$9.67K |
|
230
Morgan Stanley
MS
$336B
| $4.2M | 0.02% |
49,169
+2,248
| +5% | +$192K |
|
231
NN Inc
NNBR
$265M
| $4.18M | 0.02% |
1,750,000
+100,000
| +6% | +$151K |
|
232
Portland General Electric
POR
$6.08B
| $4.12M | 0.02% |
87,878
-15,027
| -15% | -$744K |
|
233
Camden Property Trust
CPT
$11.3B
| $4.09M | 0.02% |
37,584
-1,123
| -3% | -$121K |
|
234
Vanguard Russell 1000 ETF
VONE
$8.18B
| $4.06M | 0.01% |
20,142
-155
| -0.8% | -$29.6K |
|
235
Vanguard Value ETF
VTV
$188B
| $4.03M | 0.01% |
28,335
-3,849
| -12% | -$535K |
|
236
MDU Resources
MDU
$4.44B
| $4.02M | 0.01% |
346,802
-237,385
| -41% | -$2.67M |
|
237
T-Mobile US
TMUS
$190B
| $3.95M | 0.01% |
28,462
-2,368
| -8% | -$332K |
|
238
Cisco
CSCO
$444B
| $3.88M | 0.01% |
75,020
-6,822
| -8% | -$336K |
|
239
American International
AIG
$41.7B
| $3.81M | 0.01% |
66,230
-4,354
| -6% | -$234K |
|
240
PayPal
PYPL
$48.9B
| $3.66M | 0.01% |
54,868
-3,841
| -7% | -$262K |
|
241
Bank of America
BAC
$433B
| $3.63M | 0.01% |
126,603
-14,593
| -10% | -$416K |
|
242
Zimmer Biomet
ZBH
$17.8B
| $3.6M | 0.01% |
24,705
-1,001
| -4% | -$136K |
|
|
KALV
243
DELISTED
KalVista Pharmaceuticals
KALV
| $3.53M | 0.01% |
392,504
+122,900
| +46% | +$1.13M |
|
|
RPT
244
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $3.43M | 0.01% |
328,300
-27,650
| -8% | -$262K |
|
245
Ciena
CIEN
$55.5B
| $3.42M | 0.01% |
80,454
-8,858
| -10% | -$403K |
|
246
OGE Energy
OGE
$10.3B
| $3.39M | 0.01% |
94,474
+2,350
| +3% | +$86.5K |
|
|
K
247
DELISTED
Kellanova
K
| $3.35M | 0.01% |
52,921
-3,758
| -7% | -$240K |
|
248
Liberty Media Series C
FWONK
$24.2B
| $3.34M | 0.01% |
45,878
-416
| -0.9% | -$29.6K |
|
249
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $3.34M | 0.01% |
82,092
+575
| +0.7% | +$23.2K |
|
250
iShares Core S&P Small-Cap ETF
IJR
$109B
| $3.32M | 0.01% |
33,277
-822
| -2% | -$78.3K |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.